JHS Svendgaard Laboratories has informed that the Board of Directors of the Company at its meeting held on July 14, 2015, has not recommended any dividend for the financial year 2014-15, the Board has deferred the issue of fully convertible warrants on preferential basis till the next meeting of the Board of Directors and the Board has further approved the appointment of Mukul Pathak as an Independent Director subject to the approval of shareholders in the general meeting.
The above information is a part of company’s filings submitted to BSE.
